CN Patent

CN104039784B — 取代的增环嘧啶及其用途

Assigned to Bayer Pharma AG · Expires 2017-08-22 · 9y expired

What this patent protects

本发明涉及新的增环嘧啶、其制备方法、其单独或组合用于治疗和/或预防疾病的用途以及其用于制备用于治疗和/或预防疾病的药物的用途，更特别是其用于制备用于治疗和/或预防心血管疾病的药物的用途。

USPTO Abstract

本发明涉及新的增环嘧啶、其制备方法、其单独或组合用于治疗和/或预防疾病的用途以及其用于制备用于治疗和/或预防疾病的药物的用途，更特别是其用于制备用于治疗和/或预防心血管疾病的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN104039784B
Jurisdiction
CN
Classification
—
Expires
2017-08-22
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.